← FDA Drug Approvals (Drugs@FDA)

MEDROXYPROGESTERONE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-08-22

Drug application

FDA Application #
ANDA212824
Application type
Abbreviated New Drug Application (Generic)
Brand name
MEDROXYPROGESTERONE ACETATE
Generic name
MEDROXYPROGESTERONE ACETATE
Active ingredients
MEDROXYPROGESTERONE ACETATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
EUGIA PHARMA
Manufacturer
Eugia US LLC
First approval
2022-08-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown